Correction to: Diagnostic utility of next-generation sequencing-based panel testing in 543 patients with suspected skeletal dysplasia
Orphanet J Rare Dis
.
2022 Feb 17;17(1):59.
doi: 10.1186/s13023-022-02242-8.
Authors
Alicia Scocchia
1
,
Tiia Kangas-Kontio
2
,
Melita Irving
3
,
Matti Hero
2
4
,
Inka Saarinen
2
,
Liisa Pelttari
2
,
Kimberly Gall
1
,
Satu Valo
2
,
Johanna M Huusko
2
,
Jonna Tallila
2
,
Johanna Sistonen
2
,
Juha Koskenvuo
2
,
Tero-Pekka Alastalo
5
Affiliations
1
Blueprint Genetics Inc, Seattle, WA, USA.
2
Blueprint Genetics Oy, Espoo, Finland.
3
Department of Clinical Genetics, Guy's and St. Thomas' NHS Trust, London, UK.
4
New Children's Hospital, Pediatric Research Center, Helsinki University Hospital, Helsinki, Finland.
5
Blueprint Genetics Inc, Seattle, WA, USA. tero-pekka.alastalo@blueprintgenetics.com.
PMID:
35177119
PMCID:
PMC8851804
DOI:
10.1186/s13023-022-02242-8
No abstract available
Publication types
Published Erratum